It was highlighted that DDX11-AS1 promotes NSCLC progression through the activation of the phosphatidylinositol 3 kinase-protein kinase B (PI3K/AKT) signaling pathway [39]. Here, DDX11 is linked to non-small cell lung carcinoma.